Nucleotide excision repair is a potential therapeutic target in multiple myeloma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nucleotide excision repair is a potential therapeutic target in multiple myeloma
Authors
Keywords
-
Journal
LEUKEMIA
Volume 32, Issue 1, Pages 111-119
Publisher
Springer Nature
Online
2017-06-07
DOI
10.1038/leu.2017.182
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transcription without XPB Establishes a Unified Helicase-Independent Mechanism of Promoter Opening in Eukaryotic Gene Expression
- (2017) Sergey Alekseev et al. MOLECULAR CELL
- DNA repair of myeloma plasma cells correlates with clinical outcome: the effect of the nonhomologous end-joining inhibitor SCR7
- (2016) M. Gkotzamanidou et al. BLOOD
- Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors
- (2016) Jaegil Kim et al. NATURE GENETICS
- MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents
- (2016) M Y Shah et al. ONCOGENE
- A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer
- (2016) J. Vijai et al. Cancer Discovery
- A peptide nucleic acid targeting nuclearRAD51sensitizes multiple myeloma cells to melphalan treatment
- (2015) David Abasiwani Alagpulinsa et al. CANCER BIOLOGY & THERAPY
- A Unique Subset of Epithelial Ovarian Cancers with Platinum Sensitivity and PARP Inhibitor Resistance
- (2015) R. Ceccaldi et al. CANCER RESEARCH
- Orchestral maneuvers at the damaged sites in nucleotide excision repair
- (2015) Sergey Alekseev et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Deregulation of DNA Double-Strand Break Repair in Multiple Myeloma: Implications for Genome Stability
- (2015) Ana B. Herrero et al. PLoS One
- Differential and limited expression of mutant alleles in multiple myeloma
- (2014) N. U. Rashid et al. BLOOD
- Chromatin structure, transcriptional activity and DNA repair efficiency affect the outcome of chemotherapy in multiple myeloma
- (2014) M Gkotzamanidou et al. BRITISH JOURNAL OF CANCER
- Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
- (2014) Jens G. Lohr et al. CANCER CELL
- A Small Molecule Screen Identifies an Inhibitor of DNA Repair Inducing the Degradation of TFIIH and the Chemosensitization of Tumor Cells to Platinum
- (2014) Sergey Alekseev et al. CHEMISTRY & BIOLOGY
- Novel Targeted Agents in the Treatment of Multiple Myeloma
- (2014) Cindy Varga et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Triptolide induces apoptotic cell death of multiple myeloma cells via transcriptional repression of Mcl-1
- (2014) TOMONORI NAKAZATO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Rescue of Hippo coactivator YAP1 triggers DNA damage–induced apoptosis in hematological cancers
- (2014) Francesca Cottini et al. NATURE MEDICINE
- Monitoring Repair of UV-Induced 6-4-Photoproducts with a Purified DDB2 Protein Complex
- (2014) Matija Dreze et al. PLoS One
- Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
- (2014) Niccolo Bolli et al. Nature Communications
- The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma
- (2014) A Tagde et al. Blood Cancer Journal
- Histone Methyltransferase MMSET/NSD2 Alters EZH2 Binding and Reprograms the Myeloma Epigenome through Global and Focal Changes in H3K36 and H3K27 Methylation
- (2014) Relja Popovic et al. PLoS Genetics
- DNA repair pathways in human multiple myeloma
- (2013) Claire Gourzones-Dmitriev et al. CELL CYCLE
- In Vitro and In Vivo Antitumor Activity of a Novel Alkylating Agent, Melphalan-Flufenamide, against Multiple Myeloma Cells
- (2013) D. Chauhan et al. CLINICAL CANCER RESEARCH
- International Myeloma Working Group recommendations for global myeloma care
- (2013) H Ludwig et al. LEUKEMIA
- IMWG consensus on risk stratification in multiple myeloma
- (2013) W J Chng et al. LEUKEMIA
- Evidence for different mechanisms of ‘unhooking’ for melphalan and cisplatin-induced DNA interstrand cross-links in vitroand in clinical acquired resistant tumour samples
- (2012) Victoria J Spanswick et al. BMC CANCER
- The heat shock transcription factor 1 as a potential new therapeutic target in multiple myeloma
- (2012) Tanja Heimberger et al. BRITISH JOURNAL OF HAEMATOLOGY
- Triptolide enhances the sensitivity of multiple myeloma cells to dexamethasone via microRNAs
- (2012) Xin Huang et al. LEUKEMIA & LYMPHOMA
- Nucleotide excision repair: new tricks with old bricks
- (2012) Irene Kamileri et al. TRENDS IN GENETICS
- Bortezomib-induced "BRCAness" sensitizes multiple myeloma cells to PARP inhibitors
- (2011) P. Neri et al. BLOOD
- XPB, a subunit of TFIIH, is a target of the natural product triptolide
- (2011) Denis V Titov et al. Nature Chemical Biology
- Targeting the Fanconi Anemia/BRCA Pathway Circumvents Drug Resistance in Multiple Myeloma
- (2009) D. N. Yarde et al. CANCER RESEARCH
- Dysfunctional homologous recombination mediates genomic instability and progression in myeloma
- (2008) M. A. Shammas et al. BLOOD
- The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity
- (2007) J. Lauring et al. BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started